Dalfampridine

Product NDC
51407-876
11-digit product format
514070876
Labeler code
51407
Product ID
51407-876_1134ac0f-599a-a20b-e063-6294a90affcc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Dalfampridine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Golden State Medical Supply, Inc.
Application
ANDA206765
Marketing category
ANDA
Marketing start
2018-07-30
Substance
DALFAMPRIDINE
Active strength
10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A206765-001DALFAMPRIDINEDALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A206765-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-3087673890dc5c…
2021-03-12 10:30 UTC2021-03A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-303f01610625f2…
2019-09-15 20:21 UTC2019-09A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30b00525d2431f…
2019-07-19 19:46 UTC2019-07A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-303f0d92c62455…
2023-05-13 08:27 UTC2023-05A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30053a50430f4f…
2023-01-26 05:58 UTC2023-01A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-303bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A206765-001DALFAMPRIDINE10MGTABLET, EXTENDED RELEASE / ORALAB2018-07-30e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A206765-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A206765-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A206765-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A206765-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A206765-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A206765-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A206765-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A206765-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A206765-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A206765-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A206765-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A206765-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A206765-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A206765-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A206765-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A206765-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A206765-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A206765-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A206765-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A206765-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A206765-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A206765-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A206765-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A206765-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A206765-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A206765-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A206765-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A206765-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A206765-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A206765-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A206765-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A206765-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A206765-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A206765-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A206765-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A206765-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A206765-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A206765-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A206765-001AB1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A206765-001AB1e64feba35796…

Additional Listing Data#

Finished product
Yes
Brand name base
Dalfampridine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DALFAMPRIDINE10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
BH3B64OKL9Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
897021Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1134ac0f-59c1-a20b-e063-6294a90affccAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9109832c-cb3c-b72f-db80-0e6688f08431Product name520190619

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51407-876-60Dalfampridine60 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE601

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51407-876-60EA - Each51407-87605cf1ba9-8041-4627-9be0-60a6573938ec12024-03-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51407-876DALFAMPRIDINE TABLET, FILM COATED, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.]1Current NDC, 1 package rows20240214_1134ac0f-59c1-a20b-e063-6294a90affcc.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DalfampridineDALFAMPRIDINEAscend Laboratories, LLCe10b2d92-2824-4395-8883-6fd52c784aa42026-07-14Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206765
application number: ANDA206765
DalfampridineDALFAMPRIDINECivicaScript LLCc40dcc84-b839-44aa-94f2-886fb1c3d75c2025-07-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206765
application number: ANDA206765
DalfampridineDALFAMPRIDINEGolden State Medical Supply, Inc.1134ac0f-59c1-a20b-e063-6294a90affcc2024-02-12Warnings, Adverse reactionsExact identifier
application applno (ANDA): 206765
application number: ANDA206765
ndc (product): 51407-876

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
897021dalfampridine 10 MG 12HR Extended Release Oral TabletPSN1134ac0f-59c1-a20b-e063-6294a90affcc1
89702112 HR dalfampridine 10 MG Extended Release Oral TabletSCD1134ac0f-59c1-a20b-e063-6294a90affcc1
897021dalfampridine 10 MG 12 HR Extended Release Oral TabletSY1134ac0f-59c1-a20b-e063-6294a90affcc1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
51407-876-605140708766060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (51407-876-60) 2024-02-05NoNoCurrent